Serum levels of circulating soluble b- and t-lymphocyte attenuator in unresectable hepatocellular carcinoma as a predictor of response to atezolizumab and bevacizumab
HEPATOLOGY(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
HEPATOLOGY(2023)